Xintian Pharma(002873.SZ)

Last Updated 00:00:00
longbridge loading

Xintian Pharma released its performance for the first three quarters, with a net profit attributable to the parent company of 16.1809 million yuan, a year-on-year decrease of 73.47%

Zhitong·
SZ
002873
-1.43%
Zhitong·
SZ
002873
-1.43%

Xintian Pharma's controlling shareholder, Xintian Zhiyao, plans to reduce its holdings by no more than 7.05 million shares

Zhitong·
SZ
002873
-1.43%
Zhitong·
SZ
002873
-1.43%

Xintian Pharma: Xinlikang capsules approved to conduct clinical trials for the treatment of cancer-related fatigue

Zhitong·
SZ
002873
-1.43%
Zhitong·
SZ
002873
-1.43%

Xintian Pharma establishes a new company in traditional Chinese medicine health technology

Zhitong·
SZ
002873
-1.43%
Zhitong·
SZ
002873
-1.43%

Xintian Pharma: Subsidiary Zhongdao Health registered capital of 10 million yuan

Zhitong·
SZ
002873
-1.43%
Zhitong·
SZ
002873
-1.43%

Xintian Pharma's subsidiary has obtained an invention patent for the "Ginkgo Biloba Water Decoction Fingerprint Map"

Zhitong·
SZ
002873
-1.43%
Zhitong·
SZ
002873
-1.43%

The A-share traditional Chinese medicine sector rapidly surged, with Xintian Pharma hitting the limit up, and YIBAI PHARMACEUTICAL, Zhendong Pharmacy, ZHONGSHENGYAOYE, Hansen Pharmaceutical, and ENWEI PHARMACEUTICAL following suit

Zhitong·
SZ
301331
-0.30%
SZ
002873
-1.43%
SZ
300158
-1.75%
Zhitong·
SZ
301331
-0.30%
SZ
002873
-1.43%
SZ
300158
-1.75%

The three major A-share indices rose collectively, with a significant increase in the biopharmaceutical sector. CPO continues to squeeze shorts, while Hong Kong stocks fluctuated and fell, tech stocks retreated, and government bonds and commodities declined

Wallstreetcn·
SZ
002873
-1.43%
SH
600557
-2.04%
SH
603087
+0.79%
Wallstreetcn·
SZ
002873
-1.43%
SH
600557
-2.04%
SH
603087
+0.79%

The innovative drug sector surged in the short term, with Chimin hitting the daily limit

Zhitong·
SH
603222
-0.91%
SZ
002873
-1.43%
SZ
003020
-1.58%
Zhitong·
SH
603222
-0.91%
SZ
002873
-1.43%
SZ
003020
-1.58%

The concept of innovative drugs remains active, with Xintian Pharma and others hitting the daily limit

Zhitong·
SZ
002287
-0.54%
SH
600513
-1.17%
SH
600774
-2.38%
Zhitong·
SZ
002287
-0.54%
SH
600513
-1.17%
SH
600774
-2.38%
© 2026 Longbridge｜Disclaimer